This phase II study was designed to evaluate the activity and safety of a combination of irinotecan, docetaxel and oxaliplatin in metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma.

 
  • 本文進(jìn)行聯(lián)合依立替康、紫杉醇和奧沙利鉑治療轉移性胃腺癌和胃及食管連接部腺癌的臨床II期實(shí)驗來(lái)評價(jià)療效和安全性。
今日熱詞
目錄 附錄 查詞歷史
国内精品美女A∨在线播放xuan